NZ238430A - Aqueous compositions which gel reversibly as temperature and ph change (containing two suitable polymers); use as a carrier for medicaments - Google Patents

Aqueous compositions which gel reversibly as temperature and ph change (containing two suitable polymers); use as a carrier for medicaments

Info

Publication number
NZ238430A
NZ238430A NZ238430A NZ23843091A NZ238430A NZ 238430 A NZ238430 A NZ 238430A NZ 238430 A NZ238430 A NZ 238430A NZ 23843091 A NZ23843091 A NZ 23843091A NZ 238430 A NZ238430 A NZ 238430A
Authority
NZ
New Zealand
Prior art keywords
temperature
compositions
reversibly gelling
medicaments
carrier
Prior art date
Application number
NZ238430A
Other languages
English (en)
Inventor
Joshi Abhay
Ding Shulin
Kenneth James Himmelstein
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24149593&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NZ238430(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of NZ238430A publication Critical patent/NZ238430A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Heat Sensitive Colour Forming Recording (AREA)
  • Cosmetics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
NZ238430A 1990-06-15 1991-06-06 Aqueous compositions which gel reversibly as temperature and ph change (containing two suitable polymers); use as a carrier for medicaments NZ238430A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/539,061 US5252318A (en) 1990-06-15 1990-06-15 Reversible gelation compositions and methods of use

Publications (1)

Publication Number Publication Date
NZ238430A true NZ238430A (en) 1993-03-26

Family

ID=24149593

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ238430A NZ238430A (en) 1990-06-15 1991-06-06 Aqueous compositions which gel reversibly as temperature and ph change (containing two suitable polymers); use as a carrier for medicaments

Country Status (13)

Country Link
US (2) US5252318A (fr)
EP (1) EP0533836B1 (fr)
JP (1) JP3181912B2 (fr)
AT (1) ATE134508T1 (fr)
AU (1) AU8201391A (fr)
DE (1) DE69117509T2 (fr)
ES (1) ES2083581T3 (fr)
IE (1) IE74246B1 (fr)
IL (1) IL98320A (fr)
NZ (1) NZ238430A (fr)
PT (1) PT97977B (fr)
WO (1) WO1991019481A1 (fr)
ZA (1) ZA914559B (fr)

Families Citing this family (175)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5188826A (en) * 1988-02-08 1993-02-23 Insite Vision Incorporated Topical ophthalmic suspensions
US5521222A (en) * 1989-09-28 1996-05-28 Alcon Laboratories, Inc. Topical ophthalmic pharmaceutical vehicles
US5461081A (en) * 1989-09-28 1995-10-24 Alcon Laboratories, Inc. Topical ophthalmic pharmaceutical vehicles
US5252318A (en) * 1990-06-15 1993-10-12 Allergan, Inc. Reversible gelation compositions and methods of use
US5460834A (en) * 1991-12-13 1995-10-24 Alcon Laboratories, Inc. Combinations of polymers for use in physiological tear compositions
EP0551626A1 (fr) * 1991-12-19 1993-07-21 LEK, tovarna farmacevtskih in kemicnih izdelkov, d.d. Gel thermoréversible utile comme excipient pharmaceutique pour une formation galénique
WO1993017664A1 (fr) * 1992-03-02 1993-09-16 Alcon Laboratories, Inc. Combinaisons de polymeres cellulosiques et de polymeres de vinyle carboxy et leur utilisation dans des compositions pharmaceutiques
SE512871C2 (sv) * 1992-08-20 2000-05-29 Santen Oy Oftalmologisk beredning innehållande pilokarpin och ytterligare medel för behandling av okular hypertension
DK0661045T3 (da) * 1992-09-18 2002-10-28 Yamanouchi Pharma Co Ltd Hydrogelpræparat med forsinket frigivelse
ES2141775T3 (es) * 1993-04-16 2000-04-01 Wakamoto Pharma Co Ltd Composicion medicinal a base de agua termicamente gelificante reversible.
WO1995000143A1 (fr) * 1993-06-24 1995-01-05 Leiras Oy Composition a usage ophtalmique
AU7668894A (en) * 1993-08-13 1995-03-14 Vitaphore Corporation Hydrogel-based microsphere drug delivery systems
KR950007873A (ko) * 1993-09-20 1995-04-15 후꾸하라 요시하루 생리 활성 물질 지속 방출형의 의약 제제
US5458879A (en) * 1994-03-03 1995-10-17 The Procter & Gamble Company Oral vehicle compositions
WO1995024430A2 (fr) 1994-03-04 1995-09-14 University Of Washington Copolymeres en blocs et greffes, et procedes les concernant
SE9401109D0 (sv) * 1994-03-31 1994-03-31 Leiras Oy Opthalmic composition II
SE9401108D0 (sv) * 1994-03-31 1994-03-31 Leiras Oy Ophthalmic composition I
US5585398A (en) * 1994-07-15 1996-12-17 Ernst; Amy A. Topical anesthetic comprising lidocaine, adrenaline, and tetracaine, and its method of use
US5840338A (en) * 1994-07-18 1998-11-24 Roos; Eric J. Loading of biologically active solutes into polymer gels
US5603955A (en) * 1994-07-18 1997-02-18 University Of Cincinnati Enhanced loading of solutes into polymer gels
GB9415290D0 (en) 1994-07-28 1994-09-21 Zeneca Ltd Gel formation
US5599534A (en) * 1994-08-09 1997-02-04 University Of Nebraska Reversible gel-forming composition for sustained delivery of bio-affecting substances, and method of use
US5827835A (en) * 1994-08-30 1998-10-27 Alcon Laboratories, Inc. Thermally-gelling emulsions
WO1996006597A1 (fr) * 1994-08-30 1996-03-07 Alcon Laboratories, Inc. Excipients ophtalmiques a gelification thermique contenant des ethers cellulosiques
US5516808A (en) * 1994-10-27 1996-05-14 Sawaya; Assad S. Topical cellulose pharmaceutical formulation
US5985383A (en) * 1995-03-15 1999-11-16 Acushnet Company Conforming shoe construction and gel compositions therefor
US5955159A (en) * 1995-03-15 1999-09-21 Acushnet Company Conforming shoe construction using gels and method of making the same
US5939485A (en) * 1995-06-19 1999-08-17 Medlogic Global Corporation Responsive polymer networks and methods of their use
US5939157A (en) * 1995-10-30 1999-08-17 Acushnet Company Conforming shoe construction using gels and method of making the same
DE19511322C2 (de) * 1995-03-28 1999-09-02 Mann Gerhard Chem Pharm Fab Sterile Augengele mit einem Gehalt an mittelkettigen Triglyceriden und Verfahren zu deren Herstellung
CA2230727A1 (fr) * 1995-06-16 1997-01-03 Medlogic Global Corporation Reticulats polymeriques sensibles et leurs procedes d'utilisation
JP3766707B2 (ja) * 1995-10-25 2006-04-19 ディップソール株式会社 亜鉛及び亜鉛合金の撥水処理用水溶性組成物及び撥水処理方法
US5766704A (en) * 1995-10-27 1998-06-16 Acushnet Company Conforming shoe construction and gel compositions therefor
US6610292B2 (en) * 1995-11-22 2003-08-26 Ista Pharmaceuticals, Inc. Use of hyaluronidase in the manufacture of an ophthalmic preparation for liquefying vitreous humor in the treatment of eye disorders
US5866120A (en) 1995-11-22 1999-02-02 Advanced Corneal Systems, Inc. Method for accelerating clearance of hemorrhagic blood from the vitreous humor with hyaluronidase
WO1997020578A1 (fr) * 1995-12-04 1997-06-12 University Of Miami Corticosteroide sans conservateur pour application locale, destine au traitement du syndrome de l'oeil sec, de la keratite filamenteuse, et du retard de clairance lacrymale
US5723131A (en) * 1995-12-28 1998-03-03 Johnson & Johnson Vision Products, Inc. Contact lens containing a leachable absorbed material
US6280745B1 (en) 1997-12-23 2001-08-28 Alliance Pharmaceutical Corp. Methods and compositions for the delivery of pharmaceutical agents and/or the prevention of adhesions
US5945100A (en) 1996-07-31 1999-08-31 Fbp Corporation Tumor delivery vehicles
EP0920338A2 (fr) * 1996-08-12 1999-06-09 MedLogic Global Corporation Composition destinee a des applications pharmaceutiques
US5888493A (en) * 1996-12-05 1999-03-30 Sawaya; Assad S. Ophthalmic aqueous gel formulation and related methods
AU5906898A (en) * 1997-01-02 1998-07-31 Medlogic Global Corporation Responsive polymer networks and methods of their use
WO1998032433A1 (fr) * 1997-01-24 1998-07-30 Medlogic Global Corporation Structures de forme adaptable
WO1998055147A2 (fr) * 1997-06-06 1998-12-10 Battelle Memorial Institute Copolymere a gelification reversible, et son procede d'obtention
GB9718568D0 (en) 1997-09-03 1997-11-05 Chauvin Pharmaceuticals Limite Compositions
US20040063678A1 (en) * 1997-10-06 2004-04-01 Bausch & Lomb Incorporated Dexamethasone Gel
DE19744113A1 (de) * 1997-10-06 1999-04-15 Mann Gerhard Chem Pharm Fab Dexamethason-Gel
US6417247B1 (en) * 1997-10-14 2002-07-09 Beth L. Armstrong Polymer/ceramic composites
AU753206B2 (en) * 1997-12-23 2002-10-10 Alliance Pharmaceutical Corporation Methods and compositions for the delivery of pharmaceutical agents and/or the prevention of adhesions
US20040228794A1 (en) * 1998-04-10 2004-11-18 Battelle Memorial Institute Therapeutic agent carrier compositions
US6159483A (en) * 1998-06-01 2000-12-12 Colgate-Palmolive Company Stabilized liquid aqueous composition
US5968480A (en) * 1998-07-09 1999-10-19 Colgate Palmolive Company Oral composition exhibiting enhanced antiplaque efficacy
US6337130B1 (en) 1998-07-30 2002-01-08 Zeneca Limited Acid-triggered release microcapsules
EP1109563A4 (fr) 1998-08-04 2009-07-22 Madash Llp Hydrogels sensibles a la chaleur a terminaison modifiee
CN1169573C (zh) * 1998-09-28 2004-10-06 参天制药株式会社 用于治疗角结膜障碍的、包含作为活性组分的钠尿肽的泪液分泌促进剂或滴眼剂
US6312666B1 (en) 1998-11-12 2001-11-06 3M Innovative Properties Company Methods of whitening teeth
US6312667B1 (en) 1998-11-12 2001-11-06 3M Innovative Properties Company Methods of etching hard tissue in the oral environment
US6669927B2 (en) 1998-11-12 2003-12-30 3M Innovative Properties Company Dental compositions
US6245740B1 (en) * 1998-12-23 2001-06-12 Amgen Inc. Polyol:oil suspensions for the sustained release of proteins
US6451346B1 (en) * 1998-12-23 2002-09-17 Amgen Inc Biodegradable pH/thermosensitive hydrogels for sustained delivery of biologically active agents
EP1185309B1 (fr) * 1999-06-11 2006-10-04 Cytyc Corporation Composition liquide de gel pour remplir un canal galactophore d'un sein avant une ablation chirurgicale de ce canal ou d'autres tissus mammaires
US6521431B1 (en) * 1999-06-22 2003-02-18 Access Pharmaceuticals, Inc. Biodegradable cross-linkers having a polyacid connected to reactive groups for cross-linking polymer filaments
US20040037891A1 (en) * 1999-10-04 2004-02-26 Karagoezian Hampar L. Synergistic antimicrobial ophthalmic and dermatologic preparations containing chlorite and hydrogen peroxide
US20040033260A1 (en) * 1999-10-19 2004-02-19 The Procter & Gamble Company Compositions for prevention and treatment of cold and influenza-like symptoms comprising chelated zinc
US20040234457A1 (en) * 1999-10-19 2004-11-25 The Procter & Gamble Company Methods of preventing and treating SARS using low pH respiratory tract compositions
WO2001041735A2 (fr) * 1999-12-07 2001-06-14 Amgen Inc. Hydrogels thermosensibles biodegradable a base de pluroniques de faible poids moleculaire
FR2802097B1 (fr) * 1999-12-14 2002-12-13 Invest S Therapeutiques Essais Composition sous forme de gel prevue pour recevoir un principe actif en solution ou en suspension, notamment pour application sur une muqueuse et procede de fabrication
TWI227143B (en) 1999-12-15 2005-02-01 Guo-Jiun Sung In situ gel formation for ophthalmic delivery by combining Pluronic/Carbopol medic composition and its preparing method
US6660247B1 (en) 2000-06-23 2003-12-09 Battelle Memorial Institute Multiple stimulus reversible hydrogels
US6303290B1 (en) 2000-09-13 2001-10-16 The Trustees Of The University Of Pennsylvania Encapsulation of biomaterials in porous glass-like matrices prepared via an aqueous colloidal sol-gel process
US7803392B2 (en) * 2000-12-27 2010-09-28 University Of Kentucky Research Foundation pH-Sensitive mucoadhesive film-forming gels and wax-film composites suitable for topical and mucosal delivery of molecules
US20040076682A1 (en) * 2001-02-15 2004-04-22 Toshiyuki Kohzaki Novel ophthalmic compositions
AU2002306795A1 (en) * 2001-03-21 2002-10-08 Madash Llc Thermally reversible water in oil in water emulsions
JP2003089752A (ja) * 2001-03-23 2003-03-28 Canon Inc 刺激応答性ポリマーを含む組成物、それを含むインク組成物、並びに該インク組成物を用いた画像形成方法および装置
FR2823439A1 (fr) * 2001-04-13 2002-10-18 Oreal Composition de bain gelifiantes, relaxantes
DE10132876A1 (de) * 2001-07-06 2003-01-30 Medproject Pharma Entwicklungs Zweiphasige, tropfbare Hydrogele zur Anwendung am Auge
US20080063620A1 (en) * 2001-08-13 2008-03-13 Yissum Research Development Company Of The Hebrew University Of Jerusalem Novel reverse thermo-sensitive block copolymers
US20030082235A1 (en) * 2001-08-13 2003-05-01 Yissum Research Development Company Of The Hebrew University Of Jerusalem Novel reverse thermo-sensitive block copolymers
US6620405B2 (en) 2001-11-01 2003-09-16 3M Innovative Properties Company Delivery of hydrogel compositions as a fine mist
US20070196415A1 (en) * 2002-11-14 2007-08-23 Guohua Chen Depot compositions with multiple drug release rate controls and uses thereof
EP1446101B1 (fr) 2001-11-14 2011-03-23 Durect Corporation Compositions en depot injectables par catheter et utilisations
BR0206984A (pt) * 2001-11-14 2004-02-03 Alza Corp Composições de depósito injetáveis e uso destas
US7204997B2 (en) * 2002-01-29 2007-04-17 Supratek Pharma Inc. Responsive microgel and methods related thereto
WO2003080119A1 (fr) * 2002-03-26 2003-10-02 Yissum Research Development Company Of The Hebrew University Of Jerusalem Composites biomedicaux sensibles
US20030204180A1 (en) * 2002-04-30 2003-10-30 Kimberly-Clark Worldwide, Inc. Temperature responsive delivery systems
EP1878447A3 (fr) * 2002-05-09 2008-12-31 Ultrast LLC Milieu d'amélioration de contraste ou commodité pour examens ultrasoniques, endoscopiques et autres examens médicaux
AU2003239850B2 (en) * 2002-05-09 2008-08-28 Ultrast Llc Medium for contrast enhancement use for ultrasonic, endoscopic and other medical examinations
DE10224352A1 (de) * 2002-06-01 2003-12-11 Mueller Schulte Detlef Thermosensitive Polymerträger mit veränderbarer physikalischer Struktur für die biochemische Analytik, Diagnostik und Therapie
JP3891571B2 (ja) * 2002-06-14 2007-03-14 キヤノン株式会社 機能性組成物、それを用いた画像形成方法及び画像形成装置
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
EP2030611A1 (fr) 2002-07-31 2009-03-04 Alza Corporation Compositions de dépôt de polymère multimode injectable et utilisations associées
ES2319400T3 (es) 2002-07-31 2009-05-07 Durect Corporation Composiciones deposito inyectables y empleo de las mismas.
US20060039979A1 (en) * 2002-12-04 2006-02-23 Kazuhito Yamada Drug delivery system using subconjunctival depot
US20040185013A1 (en) * 2003-01-30 2004-09-23 Burgio Paul A. Dental whitening compositions and methods
US20040151691A1 (en) * 2003-01-30 2004-08-05 Oxman Joel D. Hardenable thermally responsive compositions
US7223826B2 (en) * 2003-01-30 2007-05-29 3M Innovative Properties Company Amide-functional polymers, compositions, and methods
IL155866A0 (en) * 2003-05-12 2003-12-23 Yissum Res Dev Co Responsive polymeric system
US7947295B2 (en) 2003-06-13 2011-05-24 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of two polymers
KR20110098863A (ko) 2003-06-13 2011-09-01 알콘, 인코퍼레이티드 시너지성의 2개의 폴리머 배합물을 포함하는 안과용 조성물
TWI336257B (en) 2003-06-13 2011-01-21 Alcon Inc Ophthalmic compositions containing a synergistic combination of three polymers
US7914803B2 (en) 2003-06-13 2011-03-29 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of three polymers
US20050002996A1 (en) * 2003-07-02 2005-01-06 Milan Sojka Sustained release compositions and controlled delivery method
US20050059583A1 (en) 2003-09-15 2005-03-17 Allergan, Inc. Methods of providing therapeutic effects using cyclosporin components
DE10350248A1 (de) * 2003-10-28 2005-06-16 Magnamedics Gmbh Thermosensitive, biokompatible Polymerträger mit veränderbarer physikalischer Struktur für die Therapie, Diagnostik und Analytik
GB2408937A (en) * 2003-12-09 2005-06-15 Johnson & Johnson Medical Ltd pH dependent medicinal compositions
GB0329507D0 (en) * 2003-12-19 2004-01-28 Guillon Michel Contect lens
US20140162965A1 (en) 2004-08-25 2014-06-12 Aegis Therapeutics, Inc. Compositions for oral drug administration
US9114069B2 (en) 2004-08-25 2015-08-25 Aegis Therapeutics, Llc Antibacterial compositions for drug administration
US8268791B2 (en) 2004-08-25 2012-09-18 Aegis Therapeutics, Llc. Alkylglycoside compositions for drug administration
US9895444B2 (en) 2004-08-25 2018-02-20 Aegis Therapeutics, Llc Compositions for drug administration
US20060046962A1 (en) 2004-08-25 2006-03-02 Aegis Therapeutics Llc Absorption enhancers for drug administration
EP2457580A1 (fr) 2004-08-25 2012-05-30 The UAB Research Foundation Activateurs de l'absorption pour l'administration de médicaments
US20090047347A1 (en) * 2005-07-29 2009-02-19 Aegis Therapeutics, Inc. Compositions for Drug Administration
US20060089590A1 (en) * 2004-10-27 2006-04-27 John Higuchi Methods and devices for sustained in-vivo release of an active agent
US20060142234A1 (en) * 2004-12-23 2006-06-29 Guohua Chen Injectable non-aqueous suspension
US20060147485A1 (en) * 2005-01-04 2006-07-06 Morten Pedersen Oil-in-water formulation of avermectins
DE102005035879A1 (de) * 2005-07-30 2007-02-01 Paul Hartmann Ag Hydrogel
US20070048338A1 (en) * 2005-08-26 2007-03-01 Ladd Byron S Compositions and methods for surface treatment in medical and surgical procedures
US7982066B2 (en) 2005-12-09 2011-07-19 Novalife, Inc. High protein supplement
US20070248630A1 (en) * 2006-04-20 2007-10-25 Friden Phillip M Pharmaceutical formulations for iontophoretic methotrexate delivery
CA2652752A1 (fr) * 2006-04-20 2007-11-01 Transport Pharmaceuticals, Inc. Formules pharmaceutiques pour livraison iontophoretique d'un medicament
WO2007130364A2 (fr) * 2006-05-01 2007-11-15 Riolan Technologies, Inc. Compositions, procédés et trousses pour le traitement des yeux secs
EP1873205A1 (fr) * 2006-06-12 2008-01-02 Corning Incorporated Mélanges thermosensibles et leurs utilisations
CA2714867A1 (fr) 2006-06-23 2007-12-27 Candace B. Pert Peptide pharmaceutiquement actif ne formant pas d'agregats
US8226949B2 (en) 2006-06-23 2012-07-24 Aegis Therapeutics Llc Stabilizing alkylglycoside compositions and methods thereof
EP2056855B1 (fr) 2006-08-31 2014-09-17 Clinuvel Pharmaceuticals Limited Dérivés de la msh-alpha pour le traitement de photodermatoses
WO2008053810A1 (fr) * 2006-10-30 2008-05-08 Mitsui Chemicals, Inc. Gel sensible au ph, procédé de fabrication dudit gel, et soupape sensible au ph
RU2340327C1 (ru) * 2007-05-03 2008-12-10 Лев Давидович Раснецов Офтальмологический гель и способ его приготовления
WO2008137874A1 (fr) * 2007-05-04 2008-11-13 Personics Holdings Inc. Système ii de bouchon d'oreille : systèmes monochambre
ES2667945T3 (es) 2007-10-08 2018-05-16 Aurinia Pharmaceuticals Inc. Composiciones oftálmicas que comprenden inhibidores de calcineurina o Inhibidores de mTOR
WO2009062167A1 (fr) * 2007-11-09 2009-05-14 Personics Holdings Inc. Systèmes à polymère électroactif
DE102007059939A1 (de) 2007-12-12 2009-06-18 Müller-Schulte, Detlef, Dr. Auflösbare, magnetische und unmagnetische Polymerträger zur Abtrennung und Wiedergewinnung von Zellen und Biosubstanzen
US8142870B2 (en) * 2007-12-13 2012-03-27 Personics Holdings Inc. Energy responsive conformal device
US9107815B2 (en) 2008-02-22 2015-08-18 Allergan, Inc. Sustained release poloxamer containing pharmaceutical compositions
DK2957292T3 (en) 2008-03-27 2018-01-22 Clinuvel Pharmaceuticals Ltd VITILIGOTERAPHY
US20090258865A1 (en) 2008-03-28 2009-10-15 Hale Biopharma Ventures, Llc Administration of benzodiazepine compositions
KR101101321B1 (ko) * 2008-11-03 2012-01-02 주식회사 엠씨티티 상처 치유를 위한 하이드로 겔 형태의 세포전달용 비히클 및 그 제조방법
US8440631B2 (en) 2008-12-22 2013-05-14 Aegis Therapeutics, Llc Compositions for drug administration
AU2010259184B2 (en) 2009-06-09 2015-08-13 Aurinia Pharmaceuticals Inc. Topical drug delivery systems for ophthalmic use
IT1397132B1 (it) * 2009-12-01 2013-01-04 Alfa Wassermann Spa Composizioni comprendenti antiinfiammatori non steroidei.
WO2011097727A1 (fr) 2010-02-10 2011-08-18 Queen's University At Kingston Changement de la force ionique de l'eau
ES2626151T3 (es) 2010-03-12 2017-07-24 Monsanto Technology Llc Composiciones agroquímicas en gel
US10154923B2 (en) 2010-07-15 2018-12-18 Eyenovia, Inc. Drop generating device
KR20150031340A (ko) 2010-07-15 2015-03-23 코린시언 아프샐믹 인코포레이티드 안과용 약물 전달
US8684980B2 (en) 2010-07-15 2014-04-01 Corinthian Ophthalmic, Inc. Drop generating device
EA201390121A8 (ru) 2010-07-15 2014-02-28 Коринтиан Офтэлмик, Инк. Способ и система для выполнения дистанционного лечения и контроля
JP6599082B2 (ja) * 2010-12-15 2019-10-30 クィーンズ ユニバーシティー アット キングストン 半透膜を隔てた浸透圧勾配を調整するための切替可能水組成物および方法
GB201100820D0 (en) 2011-01-18 2011-03-02 Guillon Michel Lenses
EP2487185A1 (fr) 2011-02-11 2012-08-15 Clinuvel Pharmaceuticals Limited Hexapeptide ayant une activité améliorée pour la réparation de l'ADN cellulaire de cellules dermiques
RU2013142684A (ru) 2011-02-22 2015-03-27 Реджентс Оф Юниверсити Оф Миннесота (Сша) Инкапсулированные в диоксиде кремния биоматериалы
US20160144038A1 (en) 2014-11-20 2016-05-26 Broda International, LLC Water-soluble supramolecular complexes
PT2689774T (pt) 2011-03-21 2019-04-05 Broda Tech Co Ltd Composições de hidrogel termo-reversíveis reversivamente
BR112013026534A2 (pt) * 2011-04-22 2016-12-27 Alcon Res Ltd composição oftálmica com um sistema de realce da viscosidade tendo dois diferentes agentes de realce da viscosidade
WO2012158964A2 (fr) 2011-05-18 2012-11-22 Eumederis Pharmaceuticals, Inc. Substances pharmaceutiques peptidiques améliorées servant à lutter contre l'ostéoporose
ES2917973T3 (es) 2011-06-14 2022-07-12 Neurelis Inc Administración de benzodiacepina
AU2012312816A1 (en) 2011-09-22 2014-04-24 Bausch & Lomb Incorporated Ophthalmic gel compositions
US20130101547A1 (en) 2011-10-19 2013-04-25 Allergan, Inc. Thermoresponsive compositions for dermatological use and methods thereof
CN104487028A (zh) 2011-12-12 2015-04-01 艾诺维亚股份有限公司 高模量聚合物喷射器机构、喷射器装置及其使用方法
RU2672596C2 (ru) * 2012-01-23 2018-11-16 Аллерган, Инк. Биологически разлагаемые или биологически разрушаемые микросферы или микрочастицы длительного высвобождения, суспендированные в затвердевающем депообразующем инъекцируемом лекарственном составе
JP2015526515A (ja) 2012-08-31 2015-09-10 ボシュ・アンド・ロム・インコーポレイテッドＢａｕｓｃｈ ＆ Ｌｏｍｂ Ｉｎｃｏｒｐｏｒａｔｅｄ オメガ３脂肪酸を有する眼用組成物
US10005817B2 (en) 2012-11-20 2018-06-26 Eumederis Pharmaceuticals, Inc. Peptide pharmaceuticals
JP6525456B2 (ja) 2012-11-20 2019-06-05 メデリス ダイアビーティーズ，エルエルシー インスリン抵抗性のための改善されたペプチド製剤
US9534236B2 (en) 2013-03-08 2017-01-03 Regents Of The University Of Minnesota Membranes for wastewater-generated energy and gas
CN105764491A (zh) 2013-12-09 2016-07-13 度瑞公司 药物活性剂复合物、聚合物复合物，以及包括其的组合物和方法
KR20230084337A (ko) 2014-05-28 2023-06-12 메더리스 다이어비티즈, 엘엘씨 인슐린 저항성에 대한 개선된 펩티드 약제
US10035719B2 (en) 2014-10-15 2018-07-31 Regents Of The University Of Minnesota System and membrane for wastewater-generated energy and gas
ES2966595T3 (es) 2015-01-26 2024-04-23 Bausch & Lomb Composición de suspensión oftálmica
WO2016187426A1 (fr) 2015-05-19 2016-11-24 Amorphex Therapeutics Llc Dispositif de distribution de faible dose prolongée de médicament de suppression de myopie
CA3002384C (fr) 2015-10-25 2021-02-16 Iview Therapeutics, Inc. Formulations pharmaceutiques qui forment un gel in situ
US20190224275A1 (en) 2017-05-12 2019-07-25 Aurinia Pharmaceuticals Inc. Protocol for treatment of lupus nephritis
KR102643190B1 (ko) 2017-06-10 2024-03-04 아이노비아 인코포레이티드 유체를 취급하기 위한, 그리고 눈에 유체를 전달하기 위한 디바이스들
IL311775A (en) 2018-01-03 2024-05-01 Mederis Diabetes Llc Improved peptide drugs for the treatment of NASH and other disorders
CA3121155C (fr) * 2018-11-26 2023-09-05 Aiviva Biopharma, Inc. Gels biosolubles pharmaceutiques pour l'administration de medicament
EA202091615A1 (ru) 2018-12-21 2021-03-05 Аегис Терапьютикс, Ллс Интраназальные составы на основе эпинефрина и способы лечения заболевания
CA3167217A1 (fr) 2020-01-13 2021-07-22 Durect Corporation Systemes d'administration de medicament a liberation prolongee avec impuretes reduites et procedes associes

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB223166A (en) * 1923-07-11 1924-10-13 Albert Edward Young Improvements in or relating to the sealing of chambers used in the treatment of material in sheet form by air or gas
US4073943A (en) * 1974-09-11 1978-02-14 Apoteksvarucentralen Vitrum Ab Method of enhancing the administration of pharmalogically active agents
US4188373A (en) * 1976-02-26 1980-02-12 Cooper Laboratories, Inc. Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to mucous membranes
US4271143A (en) * 1978-01-25 1981-06-02 Alcon Laboratories, Inc. Sustained release ophthalmic drug dosage
US4407792A (en) * 1979-05-09 1983-10-04 Alcon Laboratories, Inc. Sustained release ophthalmic drug dosage
CA1141663A (fr) * 1979-09-06 1983-02-22 Yukihisa Ishii Solution ophtalmique de restutition de la pression intra-oculaire
ATE6466T1 (de) * 1979-10-26 1984-03-15 Smith And Nephew Associated Companies P.L.C. Autoklavierbare emulsionen.
US4406884A (en) * 1981-06-23 1983-09-27 The Procter & Gamble Company Topical antimicrobial composition
EP0075540B1 (fr) * 1981-09-23 1986-10-22 Ciba-Geigy Ag Un substrat absorbant revetu ou un article moulé contenant un agent actif soluble dans l'eau et/ou volatil
JPS59122422A (ja) * 1982-12-29 1984-07-14 Toko Yakuhin Kogyo Kk 口腔用消炎鎮痛ゲル剤
US4474751A (en) * 1983-05-16 1984-10-02 Merck & Co., Inc. Ophthalmic drug delivery system utilizing thermosetting gels
CA1224148A (fr) * 1983-05-16 1987-07-14 John L. Haslam Systeme de gels thermocoagulables pour la liberation de medicaments
US4474752A (en) * 1983-05-16 1984-10-02 Merck & Co., Inc. Drug delivery system utilizing thermosetting gels
US4474753A (en) * 1983-05-16 1984-10-02 Merck & Co., Inc. Topical drug delivery system utilizing thermosetting gels
WO1985002092A1 (fr) * 1983-11-14 1985-05-23 Bio-Mimetics Inc. Compositions bio-adhesives et procedes de traitement a l'aide de celles-ci
US4911920A (en) * 1986-07-30 1990-03-27 Alcon Laboratories, Inc. Sustained release, comfort formulation for glaucoma therapy
DE3440352A1 (de) * 1984-11-05 1986-05-07 Dr. Thilo & Co GmbH, 8029 Sauerlach Dry-eye-packung
JPS6267017A (ja) * 1985-09-19 1987-03-26 Sanwa Kagaku Kenkyusho:Kk 被膜形成型揮散性薬物含有軟膏剤
FR2588189B1 (fr) * 1985-10-03 1988-12-02 Merck Sharp & Dohme Composition pharmaceutique de type a transition de phase liquide-gel
US4692454A (en) * 1986-02-03 1987-09-08 Warner-Lambert Company Opthalmic use of quinolone antibiotics
US4966773A (en) * 1986-11-25 1990-10-30 Alcon Laboratories, Inc. Topical ophthalmic compositions containing microfine retinoid particles
DE3721574A1 (de) * 1987-06-30 1989-01-12 Kettelhack Riker Pharma Gmbh Arzneimittel in form von pellets mit enzymatisch kontrollierter arzneistoff-freisetzung
FR2618333B1 (fr) * 1987-07-20 1990-07-13 Merck Sharp & Dohme Composition pharmaceutique et/ou cosmetique a usage topique contenant de la gomme rhamsam
US4917892A (en) * 1988-06-28 1990-04-17 Temple University Encapsulated topical delivery system
JP2670812B2 (ja) * 1988-07-08 1997-10-29 株式会社コーセー 液状化粧料
GB2223166B (en) * 1988-09-29 1992-03-18 American Cyanamid Co Stable ophthalmic preparations containing methazolamide
US5252318A (en) * 1990-06-15 1993-10-12 Allergan, Inc. Reversible gelation compositions and methods of use

Also Published As

Publication number Publication date
EP0533836A4 (en) 1993-04-21
IL98320A0 (en) 1992-06-21
JPH05508154A (ja) 1993-11-18
JP3181912B2 (ja) 2001-07-03
IE912033A1 (en) 1991-12-18
US5441732A (en) 1995-08-15
ES2083581T3 (es) 1996-04-16
AU8201391A (en) 1992-01-07
EP0533836A1 (fr) 1993-03-31
ZA914559B (en) 1992-03-25
US5252318A (en) 1993-10-12
DE69117509D1 (de) 1996-04-04
PT97977B (pt) 1998-11-30
WO1991019481A1 (fr) 1991-12-26
IE74246B1 (en) 1997-07-16
DE69117509T2 (de) 1996-09-19
ATE134508T1 (de) 1996-03-15
EP0533836B1 (fr) 1996-02-28
PT97977A (pt) 1992-03-31
IL98320A (en) 1995-10-31

Similar Documents

Publication Publication Date Title
NZ238430A (en) Aqueous compositions which gel reversibly as temperature and ph change (containing two suitable polymers); use as a carrier for medicaments
NO993195L (no) Blanding for administrasjon av medikamenter
ES2117825T3 (es) Geles formados por la interaccion de polivinilpirrolidona con derivados de quitosano.
ATE358150T1 (de) Abbaubare polyethyleneglycolhydrogele mit kontrollierter halbwertzeit und ihre vorprodukte
AU2701792A (en) Slow release syneresing polymeric drug delivery device
SE8901672L (sv) System foer avgivning av en substans med biologisk eller farmakologisk verkan
ATE536869T1 (de) Auf glucan-film basierte wirkstoffverabreichungssysteme
EP0725628A1 (fr) Excipients ophtalmiques a gelification thermique contenant des ethers cellulosiques
DE69123795D1 (de) Pharmazeutische Zusammensetzung zur rektalen Verabreichung von Wirkstoffen mit topischer medizinischer Wirkung im Dickdarmniveau
WO2009028764A1 (fr) Gels à base de combinaisons de coacervats thermoréversibles pour l'administration de protéines
ES2066896T3 (es) Forma oral de farmaco de lipidos.
NZ218948A (en) Pharmaceutical preparations containing viscous gels for administration by syringe
ATE349202T1 (de) Formulierung auf heparin-, glycosaminoglykan- oder heparinoidbasis und verwendung der formulierung sowie der formulierungsgrundlage
WO2002045683A3 (fr) Systeme de gelification reversible pour distribution de medicaments oculaires
ATE184191T3 (de) Pharmazeutische formulierung
ITMI922603A1 (it) Composizioni farmaceutiche comprendenti un farmaco, una sostanza polimerica reticolata, un olio ed un agente tensioattivo
TR200201174T2 (tr) Florokinolon antibiyotik ilacı ve iksantan zamkı içeren farmasötik bileşimler.
DE59104870D1 (de) Orale Arzneiform und Überzugsmittel, enthaltend ein im Colon abbaubares Polysaccharid.
US5292517A (en) pH sensitive, reversible gelling, copolymeric erodible drug delivery system
EP0208313A3 (fr) Agent gélifiant
US5827835A (en) Thermally-gelling emulsions
IE790194L (en) Pharmaceutical formulation
EA200200914A1 (ru) Система контроля дозирования для однократного ежедневного приема назначенного ципрофлоксацина
DE60007074D1 (de) Sulfatierte phosphatidylinositole, ihre herstellung und verwendung
TH31645A (th) สารเติมเต็มสำหรับรูปแบบขนาดสารทางเภสัชศาสตร์เจลาทินนิ่ม